AbbVie
ABBV
$301.98
Share price
2.07%
Change (1 day)
5.75%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Market capitalization of AbbVie (ABBV)
Market cap: NZ$534.20 Billion
As of April 2025 AbbVie has a market cap of NZ$534.20 Billion. This makes AbbVie the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AbbVie from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$534.20 B | -4.23% |
| 2024 | NZ$557.77 B | 28.92% |
| 2023 | NZ$432.64 B | -3.89% |
| 2022 | NZ$450.15 B | 28.45% |
| 2021 | NZ$350.44 B | 33.67% |
| 2020 | NZ$262.17 B | 34.84% |
| 2019 | NZ$194.42 B | -4.34% |
| 2018 | NZ$203.24 B | -6.51% |
| 2017 | NZ$217.38 B | 47.97% |
| 2016 | NZ$146.91 B | 5.43% |
| 2015 | NZ$139.34 B | 4.84% |
| 2014 | NZ$132.91 B | 30.29% |
| 2013 | NZ$102.01 B | 55.48% |
| 2012 | NZ$65.60 B |
End of Day market cap according to different sources
On Apr 23rd, 2025 the market cap of AbbVie was reported to be:
NZ$523.38 Billion
NZ$523.38 Billion
NZ$521.57 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | NZ$216.51 B | -59.47% | 🇺🇸 USA |
 | NZ$165.52 B | -69.01% | 🇺🇸 USA |
 | NZ$1.281 T | 139.97% | 🇺🇸 USA |
 | NZ$251.31 B | -52.95% | 🇺🇸 USA |
 | NZ$222.02 B | -58.44% | 🇺🇸 USA |
 | NZ$29.25 B | -94.52% | 🇺🇸 USA |
 | NZ$126.57 B | -76.31% | 🇬🇧 UK |
 | NZ$359.71 B | -32.66% | 🇬🇧 UK |
 | NZ$17.30 B | -96.76% | 🇺🇸 USA |